Community Healthcare Analyst Ratings
Community Healthcare Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/17/2023 | 10.86% | Piper Sandler | $41 → $45 | Maintains | Overweight |
| 01/13/2023 | 8.4% | Janney Montgomery Scott | → $44 | Upgrades | Neutral → Buy |
| 10/07/2022 | 1.01% | Piper Sandler | $45 → $41 | Maintains | Overweight |
| 09/27/2022 | 5.94% | Evercore ISI Group | $45 → $43 | Maintains | Outperform |
| 07/11/2022 | 8.4% | Truist Securities | $49 → $44 | Maintains | Buy |
| 11/25/2020 | — | Evercore ISI Group | Upgrades | In-Line → Outperform | |
| 08/06/2020 | 35.5% | Piper Sandler | $38 → $55 | Maintains | Overweight |
| 06/08/2020 | 5.94% | Evercore ISI Group | → $43 | Downgrades | Outperform → In-Line |
| 05/14/2020 | -6.38% | Piper Sandler | $35 → $38 | Maintains | Overweight |
| 05/07/2020 | -1.45% | B. Riley Securities | → $40 | Downgrades | Buy → Neutral |
| 04/23/2020 | -3.92% | SunTrust Robinson Humphrey | $46 → $39 | Maintains | Buy |
| 03/20/2020 | -1.45% | B. Riley Securities | $47 → $40 | Upgrades | Neutral → Buy |
| 03/06/2020 | 15.79% | B. Riley Securities | $42 → $47 | Maintains | Neutral |
| 02/28/2020 | 28.11% | Baird | $48 → $52 | Maintains | Outperform |
| 11/18/2019 | — | Piper Sandler | Upgrades | Hold → Buy | |
| 11/07/2019 | 3.47% | B. Riley Securities | $38 → $42 | Maintains | Neutral |
| 07/10/2019 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
| 04/23/2019 | — | Berenberg | Initiates Coverage On | → Buy | |
| 04/10/2019 | -1.45% | Baird | → $40 | Initiates Coverage On | → Outperform |
| 03/28/2019 | -6.38% | DA Davidson | → $38 | Initiates Coverage On | → Neutral |
| 11/16/2018 | -95.07% | UBS | → $2 | Initiates Coverage On | → Sell |
| 11/12/2018 | -23.63% | B. Riley Securities | $32 → $31 | Maintains | Neutral |
| 08/13/2018 | -21.16% | B. Riley Securities | $28 → $32 | Maintains | Neutral |
| 05/11/2018 | -31.02% | B. Riley Securities | $27 → $28 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 01/17/2023 | 10.86% | 派珀·桑德勒 | $41 → $45 | 維護 | 超重 |
| 01/13/2023 | 8.4% | 詹尼·蒙哥馬利·斯科特 | → $44 | 升級 | 中性→購買 |
| 10/07/2022 | 1.01% | 派珀·桑德勒 | $45 → $41 | 維護 | 超重 |
| 09/27/2022 | 5.94% | Evercore ISI集團 | $45 → $43 | 維護 | 跑贏大盤 |
| 07/11/2022 | 8.4% | Truist證券 | $49 → $44 | 維護 | 買 |
| 11/25/2020 | — | Evercore ISI集團 | 升級 | 線內→表現優異 | |
| 08/06/2020 | 35.5% | 派珀·桑德勒 | $38 → $55 | 維護 | 超重 |
| 06/08/2020 | 5.94% | Evercore ISI集團 | → $43 | 評級下調 | 勝過→同線 |
| 05/14/2020 | -6.38% | 派珀·桑德勒 | $35 → $38 | 維護 | 超重 |
| 05/07/2020 | -1.45% | B.萊利證券 | → $40 | 評級下調 | 購買→中性 |
| 04/23/2020 | -3.92% | SunTrust Robinson Humphrey | $46 → $39 | 維護 | 買 |
| 03/20/2020 | -1.45% | B.萊利證券 | $47 → $40 | 升級 | 中性→購買 |
| 03/06/2020 | 15.79% | B.萊利證券 | $42 → $47 | 維護 | 中性 |
| 02/28/2020 | 28.11% | 貝爾德 | $48 → $52 | 維護 | 跑贏大盤 |
| 11/18/2019 | — | 派珀·桑德勒 | 升級 | 持有→購買 | |
| 11/07/2019 | 3.47% | B.萊利證券 | $38 → $42 | 維護 | 中性 |
| 07/10/2019 | — | 詹尼·蒙哥馬利·斯科特 | 評級下調 | 購買→中性 | |
| 04/23/2019 | — | 貝倫伯格 | 開始承保 | →購買 | |
| 04/10/2019 | -1.45% | 貝爾德 | → $40 | 開始承保 | →跑贏大盤 |
| 03/28/2019 | -6.38% | 達·戴維森 | → $38 | 開始承保 | →中性 |
| 11/16/2018 | -95.07% | 瑞銀集團 | → $2 | 開始承保 | →銷售 |
| 11/12/2018 | -23.63% | B.萊利證券 | $32 → $31 | 維護 | 中性 |
| 08/13/2018 | -21.16% | B.萊利證券 | $28 → $32 | 維護 | 中性 |
| 05/11/2018 | -31.02% | B.萊利證券 | $27 → $28 | 維護 | 中性 |
What is the target price for Community Healthcare (CHCT)?
社區醫療(CHCT)的目標價格是多少？
The latest price target for Community Healthcare (NYSE: CHCT) was reported by Janney Montgomery Scott on January 13, 2023. The analyst firm set a price target for $44.00 expecting CHCT to rise to within 12 months (a possible 8.40% upside). 4 analyst firms have reported ratings in the last year.
Janney Montgomery Scott於2023年1月13日報道了社區醫療保健(NYSE：CHCT)的最新目標價。這家分析公司將目標價定為44.00美元，預計CHCT將在12個月內升至(可能上漲8.40%)。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Community Healthcare (CHCT)?
社區醫療(CHCT)的最新分析師評級是多少？
The latest analyst rating for Community Healthcare (NYSE: CHCT) was provided by Janney Montgomery Scott, and Community Healthcare upgraded their buy rating.
社區醫療(NYSE：CHCT)的最新分析師評級由Janney Montgomery Scott提供，社區醫療上調了買入評級。
When is the next analyst rating going to be posted or updated for Community Healthcare (CHCT)?
社區醫療(CHCT)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Community Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Community Healthcare was filed on January 13, 2023 so you should expect the next rating to be made available sometime around January 13, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閲公共財務報表，與社區醫療保健的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。社區衞生保健的上一次評級是在2023年1月13日提交的，所以你應該預計下一次評級將在2024年1月13日左右的某個時候公佈。
Is the Analyst Rating Community Healthcare (CHCT) correct?
分析師對社區醫療保健(CHCT)的評級正確嗎？
While ratings are subjective and will change, the latest Community Healthcare (CHCT) rating was a upgraded with a price target of $0.00 to $44.00. The current price Community Healthcare (CHCT) is trading at is $40.59, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的社區醫療保健(CHCT)評級被上調，目標價為0.00美元至44.00美元。目前Community Healthcare(CHCT)的交易價格為40.59美元，在分析師的預測範圍內。